The 30-year rise of Gilead, from California startup to the biotech with the best shot yet at an effective coronavirus treatment

11:25am PDT - May 27th, 2020    ebola - Business Insider

• Meet Gilead Sciences, the 30-year-old drugmaker with one of the most promising treatments for the novel coronavirus.
• The company has a long history of developing and marketing treatments for viral diseases like HIV and hepatitis C. It's ofte…